LDHA and neoplasm: Rapalink‐1, a third‐generation mTOR inhibitor, is found to block mTORC1/2 signaling,286 accompanied by the reduction of the proportion of ALDH‐positive cells in PCa patient‐derived organoids and decreased tumor burden in xenograft mouse models.287